Growing community of inventors

Pittsburgh, PA, United States of America

Mark E Schurdak

Average Co-Inventor Count = 3.82

ph-index = 1

The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.

Forward Citations = 0

Mark E SchurdakPeter Wipf (2 patents)Mark E SchurdakDonna Mary Huryn (2 patents)Mark E SchurdakJennifer Rubin Grandis (2 patents)Mark E SchurdakMatthew G LaPorte (2 patents)Mark E SchurdakPaul A Johnston (2 patents)Mark E SchurdakRaffaele Colombo (2 patents)Mark E SchurdakAndrew Michael Stern (1 patent)Mark E SchurdakMark E Schurdak (3 patents)Peter WipfPeter Wipf (83 patents)Donna Mary HurynDonna Mary Huryn (23 patents)Jennifer Rubin GrandisJennifer Rubin Grandis (11 patents)Matthew G LaPorteMatthew G LaPorte (7 patents)Paul A JohnstonPaul A Johnston (5 patents)Raffaele ColomboRaffaele Colombo (4 patents)Andrew Michael SternAndrew Michael Stern (2 patents)
..
Inventor’s number of patents
..
Strength of working relationships

Company Filing History:

1. University of Pittsburgh (3 from 1,863 patents)


3 patents:

1. 11253594 - Drug combinations for protecting against neuronal cell death

2. 11111253 - 6-aryl-7-substituted-3-(1H-pyrazol-5-yl)-7H-[1,2,4]triazolo[3,4-b][1,3,4]thiadiazines as inhibitors of the STAT3 pathway with anti-proliferative activity

3. 10618914 - 6-aryl-7-substituted-3-(1H-pyrazol-5-yl)-7H-[1,2,4]triazolo[3,4-B][1,3,4]thiadiazines as inhibitors of the STAT3 pathway with anti-proliferative activity

Please report any incorrect information to support@idiyas.com
idiyas.com
as of
12/26/2025
Loading…